After stent implantation for ACS, ticagrelor monotherapy after <1 mo of DAPT vs. 12 mo of DAPT improved 1-y net clinical benefit.
Ann Intern Med
; 177(6): JC64, 2024 Jun.
Article
en En
| MEDLINE
| ID: mdl-38830214
ABSTRACT
SOURCE CITATION Hong SJ, Lee SJ, Suh Y, et al; T-PASS (Ticagrelor Monotherapy in Patients Treated With New-Generation Drug-Eluting Stents for Acute Coronary Syndrome) Investigators. Stopping aspirin within 1 month after stenting for ticagrelor monotherapy in acute coronary syndrome the T-PASS randomized noninferiority trial. Circulation. 2024;149562-573. 37878786.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inhibidores de Agregación Plaquetaria
/
Síndrome Coronario Agudo
/
Stents Liberadores de Fármacos
/
Ticagrelor
/
Terapia Antiplaquetaria Doble
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ann Intern Med
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Estados Unidos